Introduction
============

Diabetes mellitus is a global epidemic problem that causes public health crisis worldwide. In 2011, there were 366 million diabetic patients. This value was estimated to rise up to 522 million in 2030 ([@b1-ijsc-11-205]). Diabetes is one of the most recognizable endocrine metabolic disorders characterized by chronic hyperglycemia. Over time, it increased the risk of heart disease, stroke, diabetic nephropathy and blindness ([@b2-ijsc-11-205]). Type 1 diabetes (T1DM), the chronic autoimmune disease, results from the destruction of the insulin producing beta (*β*) cells of the pancreas, leading to a gradual decrease in *β*-cell mass. Accordingly, this type of diabetes shows absolute insulin deficiency and excessive glucose production ([@b3-ijsc-11-205]).

In recent years, stem cell therapies had opened up new horizons to treatment of diabetes mellitus. Mesenchymal stem cells (MSCs) had been shown to be an interesting therapeutic option based on their immunomodulatory properties and differentiation potentials confirmed in various experimental and clinical trial studies ([@b4-ijsc-11-205]). Adipose-derived mesenchymal stem cells (AMSCs) play a potential role as seeding cells in stem cell transplantation in animal models ([@b5-ijsc-11-205]).

It was approved that sarco (endo) plasmic reticulum calcium-ATPase (SERCA) 2b is the predominant SERCA isoform expressed in the pancreatic islet. In pancreatic *β*-cells, the metabolism of glucose results in closure of ATP-sensitive K-channels (KATP) channels resulting in depolarization of the *β*-cell. The L-type Ca^2+^ channel opens and allows the entry of Ca^2+^from the extracellular compartment. Then the P/Q type Ca^2+^channels open triggering the exocytosis of insulin granules. Insulin secretion entirely depends on Ca^2+^ influx and sequestration into ER. In order to restore Ca^2+^resting levels, cytosolic Ca^2+^ is pumped inside the ER by the SERCA2b. In the diabetic pancreas, the amount of SERCA2b is decreased in the *β*-cells leading to impaired intracellular Ca^2+^ homeostasis and insulin secretion. Increasing the level of SERCA2b in pancreas by gene therapy is a promising therapeutic strategy to correct alterations in Ca^2+^ handling in diabetic patients ([@b6-ijsc-11-205]).

Transfection of MSCs in different tissue cultures had been approved. Lipid-mediated transfection remained popular due to ease of use, low cost and adaptation to high throughput system ([@b7-ijsc-11-205]).

The present study aimed at investigating the therapeutic effect of *SERCA2b* gene transfected AMSCs on the pancreas of streptozotocin (STZ)-induced diabetes type 1 in adult male albino rat and comparing it to that of non-transfected AMSCs.

Materials and Methods
=====================

Experimental design
-------------------

This study was conducted on 58 adult male albino rats with average body weight 200 grams, housed according to the guidelines of Cairo University and were divided into the following:

Donor Group
-----------

### It included 22 rats divided into

Two rats were used for stem cell isolation, culture, phenotyping and labeling. In addition, a part of pancreas was homogenized for SERCA2b preparation. Twenty rats were used for isolation of the islets from the rats' pancreases to assess the islet calcium level. They were subdivided into 4 subgroups (5 rats each).

### Group I (Control Group)

It included 6 rats that corresponded to and were sacrificed with the experimental groups II, III and IV respectively. The first 2 rats received a single intraperitoneal (IP) injection of 0.5 ml citrate buffer. The second 2 rats received a single IP injection of 0.5 ml citrate buffer. The day following confirmation of diabetes, 1 ml of phosphate buffered saline (PBS) was given intravenous (IV) via tail vein. The third 2 rats received citrate buffer and PBS as for the 2^nd^ 2 rats, in addition to 1.5 *μ*l lipofectamine via the tail vein.

### Group II (Diabetic Group)

It included 10 rats. Diabetes was induced by a single IP injection of STZ (Sigma Company, St. Louis, Mo, USA) in a powder form as 1 g vial. The required dose (50 mg/kg body weight) ([@b8-ijsc-11-205]) was weighed using a digital scale and dissolved in 0.5 citrate buffer for each rat. Three days following STZ injection, diabetes was confirmed by measuring the blood glucose level. The animals were considered diabetic if their blood glucose level was higher than 200 mg/dl ([@b9-ijsc-11-205]).

### Group III (AMSCs Group)

It included 10 rats. On the day following confirmation of diabetes, 1×10^6^ of cultured and labeled rat AMSCs, suspended in 1 ml PBS, were injected into the tail vein ([@b10-ijsc-11-205]).

### Group IV (SERCA2b transfected AMSCs Group)

It included 10 rats. On the day following confirmation of diabetes, 1×10^6^ of cultured and labeled *SERCA2b* transfected AMSCs were injected as in group III.

In group I (control) and the corresponding experimental groups II, III and IV, the rats were sacrified 3 weeks following the day of confirmation of diabetes.

In Vitro Studies
----------------

### Isolation and propagation of AMSCs from rats ([@b11-ijsc-11-205], [@b12-ijsc-11-205])

Under sterile conditions, rats were euthanized with carbon dioxide (CO~2~), their abdomens were cut open and the adipose tissues were removed. After the adipose tissues were washed with saline solution, all the tissues were collected and incubated in Dulbecco's modified Eagle's medium (DMEM), (GIBCO/BRL) supplemented with 10% fetal bovine serum (FBS) (GIBCO/BRL). Nucleated cells were isolated with a density gradient \[Ficoll/Paque (Pharmacia)\] and resuspended in complete culture medium supplemented with 1% penicillin-streptomycin (GIBCO/BRL). Cells were incubated at 37°C in 5% humidified CO2 for 12\~14 days as primary culture or upon formation of large colonies. When large colonies developed (80\~90% confluence), cultures were washed twice with PBS and cells were trypsinized with 0.25% trypsin in 1millimolar EDTA (GIBCO/BRL) for 5 minutes at 37°C. After centrifugation (at 2400 rpm for 20 minutes), cells were resuspended with serum-supplemented medium and incubated in 50 cm2 culture flask Falcon). The resulting cultures were referred to as first-passage cultures. On day 14, the adherent colonies of cells were trypsinized, and counted.

### Characterization of AMSCs

Adherent cells (at the end of 3rd passage) were trypsinized and adjusted to 1×10^6^ cells/ml determined by hemocytometer and incubated with 10 *μ*l of monoclonal antibodies: CD34 and CD44 (Beckman coulter, USA) at 4°C in the dark. After 20 minutes incubation, 2 ml of PBS containing 2% fraction crystallizable solution (FCS) were added to each tube of monoclonal treated cells. The mixtures were then centrifuged for 5 minutes at 2500 rpm followed by discarding the supernatant and resuspending cells in 500 *μ*l PBS containing 2% FCS. Cell analysis was performed using CYTOMICS FC 500 Flow Cytometer (Beckman coulter, FL, USA) and analyzed using CXP Software version 2.2 ([@b10-ijsc-11-205]). Immunohistochemical characterization was performed by using streptavidin immunoperoxidase technique for CD44 and CD34 ([@b13-ijsc-11-205]).

### Labeling of stem cells with PKH26 dye ([@b14-ijsc-11-205])

Non-transfected AMSCs cells were harvested during the 4th passage and were labeled with PKH26 fluorescent linker dye to be examined by fluorescent microscope.

### SERCA2b preparation

Pancreatic tissues were homogenized in a solution containing (mM) 250 sucrose, 5 hydroxyethylpiperazine- N′-2-ethanesulfonic acid (HEPES) and 0.2 phenylmethanesulfonyl fluoride (PMSF), using a Polytron homogenizer. Ca^2+−^dependent Ca^2+−^ATPase activity in homogenates was measured at 37°C. The data were analyzed by nonlinear regression with computer software (GraphPad Software). Processing for ribonucleic acid (RNA) extraction was followed by using reverse transcriptase (for complementary DNA (cDNA) synthesis ([@b15-ijsc-11-205]).

### Lipofectamine 3000 transfection and characterization of transfected cells ([@b16-ijsc-11-205])

The cells were plated at a confluency of 50% (500,000 cells/plate) one day prior to transfection. 1.5 *μ*l Lipofectamine 3000 reagent (Invitrogen) and 1.5 *μ*g SERCA2b labeled with green fluorescent protein (GFP) were used for transfection using serum-free DMEM. GFP directly fuses to selected locations on SERCA2b ([@b17-ijsc-11-205]). Culture media were changed 4 hours after transfection and replaced with DMEM/10% FBS without antibiotics. To assess transfection efficiency, cells labeled with GFP are first visualized via fluorescence microscopy for qualitative assessment of protein expression, morphology and viability. Cells were then prepared for flow cytometry by aspirating the medium and replacing it with 250 *μ*l of a 7 : 3 mixture of TrypLE reagent: 1 X DPBS. Cells were incubated at 37°C for 10 min and then pipetted up and down to ensure single cells for flow cytometry analysis. The cells were then allowed to proliferate and differentiate in DMEM/2% FBS.

### Isolation of pancreatic islets ([@b18-ijsc-11-205])

Pancreatic islets were aseptically isolated from rat pancreases according to the optimized protocol described by Shewade et al. ([@b16-ijsc-11-205]). Aseptically excised rat pancreases were minced into three 1-mm pieces and digested with collagenase (Sigma Aldrich, USA) (1 mg/ml) for 10 min. The collagenase was then inactivated with two washes of RPMI 1640 containing 10% fetal calf serum (Sigma Aldrich, USA) and the samples were seeded into the same medium at one pancreas per flask. The primary cultures were incubated at 37°C under 5% CO2 for 48 h. The isolated islets of the 1st subgroup were considered control. The isolated islets of the 2nd subgroup were exposed to STZ (5 mM) for 1 h at 37°C. The STZ solution was prepared in phosphate-buffered saline (Sigma Aldrich, USA). The isolated islets of the 3rd subgroup were exposed to STZ (5 mM) for 1 h and then treated with AMSCs (10 *μ*M). The isolated islets of the 4th subgroup were exposed to STZ (5 mM) for 1 h and then treated with *SERCA 2b* transfected AMSCs (10 *μ*M).

### Assessment of islet calcium level ([@b19-ijsc-11-205])

The calcium level was assessed in the islet culture medium after treatment by colorimetric methods according to the kit instructions. The analytical kits were supplied by Quimica Clinica Aplicada SA (Amposta, Spain).

Animal studies
--------------

### Serological study

Before sacrifice tail vein blood samples were collected at the end of the 3^rd^ week from groups I, II, III and IV for blood glucose and plasma insulin levels estimation.

Plasma insulin level was measured by enzyme immunoassay of 25-l aliquots of plasma with a Rat Insulin ELISA kit (DRG, USA). During incubation, insulin in the sample reacted with peroxidase-conjugated anti-insulin antibodies, which were bound to the plastic surface of the microtitration well. The bound conjugate was detected by reaction with 3, 3′, 5, 5′-tetramethylbenzidine. The reaction was stopped by adding acid to give a colorimetric end point that was read spectrophotometrically ([@b20-ijsc-11-205]).

### Histological study

The animals were sacrificed by cervical dislocation ([@b21-ijsc-11-205]). A central ventral midline incision was performed for each animal. The pancreas specimens were excised and fixed in 10% formol saline for 48 hours. Paraffin blocks and 5 *μ*m thick sections were prepared. For semithin sections, pancreas specimens (1 mm) were processed for embedding in epoxy resin, cut at1 μm thickness and staind with toluidine blue. Sections were subjected to

1.  Toluidine blue stain ([@b22-ijsc-11-205])

2.  Masson's trichrome stain ([@b23-ijsc-11-205]).

3.  CD44 (IW-PA1021, IHW, Ellicott City, USA) immunostaining, for detecting endogenous and exogenous undifferentiated MSCs ([@b24-ijsc-11-205]).

4.  Insulin (EPR17359 Ab, Abcam, USA) immunostaining, for detecting *β* cells ([@b25-ijsc-11-205]).

0.1 ml prediluted primary rabbit polyclonal CD44 antibody was applied to sections for 60 minutes, tonsil sections were considered +ve control and the reaction is membranous. 0.1 ml diluted 1ry antibody rabbit monoclonal insulin antibody was applied to sections for 60 minutes pancreas sections were considered +ve control and the reaction is cytoplasmic,

### Morphometric study

Using Leica Qwin 500 LTD (Cambridge, UK) computer assisted image analysis system, assessment of the area percent (%) of collagen fibers performed in Masson's trichrome stained sections. The measurements were done in 10 low power fields (PFs) in control and experimental groups. Insulin IE and CD44 + ve cells were measured using binary mode. The measurements were done in 10 high PFs in control and experimental groups. The areas of chosen colors were masked by a blue binary color inside a standard measuring frame of area.

### Quantitative polymerase chain reaction (qPCR)

Evaluation of formalin-fixed paraffin-embedded (FFPE) pancreas specimens by real time qPCR was performed ([@b26-ijsc-11-205]). Reverse Transcription is carried out with the SuperScript First-Strand Synthesis System for reverse transcriptase (RT)-PCR. The following procedure is based on Invitrogen's protocol. The *SERCA2b* primer using the *5′-oligonucleotide primer 5′-AC GTC AAT GGG TCG ACT ATT TAC G-3′ and 3′-oligonucleotide primer 5′-AGA AGG CAC AGT CGA GGC TG-3′* (mixture was prepared in each tube: 5 *μ*g total RNA and 3 *μ*l random hexamers). The samples were incubated at 65°C for 5 min and then on ice for at least 1 min. Reaction master mixture was prepared for each reaction then added to the RNA/primer mixture, mix briefly, and then placed at room temperature for 2 minutes. 1 *μ*l (50 units) of SuperScript II RT was added to each tube, mixed and incubated at 25°C for 10 min. The tubes were incubated at 42°C for 50 min, heat inactivated at 70°C for 15 min, and then chilled on ice. 1 *μ*l RNAase H was added and incubated at 37°C for 20 min. The 1st strand complementary deoxyribonucleic acid (cDNA) was stored at −20°C until use for real-time PCR. The primer concentrations were normalized, gene-specific and reverse primer pair were mixed. Each primer (forward or reverse) concentration in the mixture is 5 pmol/*μ*l. The PCR program was set up on ABI Prism standard deviation score (SDS) 7000. A copy of the setup file was saved and all PCR cycles were deleted (used for later dissociation curve analysis). 50°C 2 min, 1 cycle, 95°C 10 min, 1 cycle, 95°C 15 seconds → 60°C 30 seconds → 72°C 30 seconds, 40 cycles and 72°C 10 min, 1 cycle. A real-time PCR reaction mixture can be either 50 *μ*l or 25 *μ*l. After PCR is finished, the tubes were removed from the machine. The PCR specificity was examined by 3% agarose gel using 5 *μ*l from each reaction. The setup file was saved and the real-time PCR result was analyzed with the SDS 7000 software. *β*-*actin* was used as internal control to normalize values with the following primer (forward primer: *5′-CCT TCCTGGGCATGGAGTCCT-3′ & reverse primer: 5′-GGAGCAATGATCTTGATCTTC-3′* ).

### Statistical analysis ([@b27-ijsc-11-205])

Any significant ANOVA was followed by Bonferroni post-hoc test to detect which pairs of groups caused the significant difference. p-values \<0.05 were considered statistically significant. Calculations were made on Statistical Package for the Social Sciences (SPSS) version 16.

Results
=======

General observations included lethargy and polyurea noticed in diabetic rats that improved in treated groups. Death of 2 diabetic rats was recorded at the beginning of the experiment.

In vitro data
-------------

### Characterization of AMSCs and transfected AMSCs

AMSCs appeared mostly spindle in shape, immunostaining showed +ve membranous brownish reaction for CD44 (arrows) ([Fig. 1A](#f1-ijsc-11-205){ref-type="fig"}) and −ve for CD34 (arrows) ([Fig. 1B](#f1-ijsc-11-205){ref-type="fig"}). Immunophenotyping of AMSCs by flow cytometry showed 96% of the cells +ve for CD44 ([Fig. 1C](#f1-ijsc-11-205){ref-type="fig"}).

Transfected cells appeared mostly as spindle fluroscent labeled cells ([Fig. 1D](#f1-ijsc-11-205){ref-type="fig"}). Immunophenotyping of transfected AMSCs by flow cytometry showed 93.3% of the cells GFP labeled ([Fig. 1E](#f1-ijsc-11-205){ref-type="fig"}).

### Islet calcium level

The mean calcium level values± standard deviation (SD) were (1.41±0.03) in the control group, (0.77±0.02) in the diabetic group, (1.03±0.04) in the AMSCs group and (1.31±0.03) in the SERCA2b transfected AMSCs group. The previous values indicated a significant decrease in the diabetic group compared to the other groups and in the AMSCs group compared to control and transfected AMSCs group.

Animal data
-----------

### Serological results

Blood glucose level values indicated a significant increase in the diabetic group before sacrifice compared to the other groups. The plasma insulin values revealed a significant decrease in the diabetic group compared to the other groups and in the AMSCs group compared to control and SERCA2b transfected AMSCs groups ([Table 1](#t1-ijsc-11-205){ref-type="table"}).

### Histological phenotyping

In toluidine blue stained sections, all control rats demonstrated islet cells exhibiting pale nuclei and secretory granules ([Fig. 2A](#f2-ijsc-11-205){ref-type="fig"}). Sections of group II recruited shrunken islets exhibiting few cells with absent secretory granules ([Fig. 2B](#f2-ijsc-11-205){ref-type="fig"}). Sections of group III showed condensed nuclear chromatin of few islet cells, multiple pale nuclei and secretory granules in most of islet cells ([Fig. 2C](#f2-ijsc-11-205){ref-type="fig"}). Sections of group IV demonstrated condensed nuclear chromatin of few islet cells, pale nuclei and secretory granules in most cells ([Fig. 2D](#f2-ijsc-11-205){ref-type="fig"}).

In Masson's trichrome stained sections, group I revealed fine collagen fibers and group II recruited increased collagen fibers between the acini and among the islet cells ([Fig. 3A, B](#f3-ijsc-11-205){ref-type="fig"}). Group III demonstrated minimal increase in the collagen content around vessels and fine collagen fibers among the islet cells and group IV showed fine collagen fibers ([Fig. 3C, D](#f3-ijsc-11-205){ref-type="fig"}).

In fluorescent labeled sections, group III showed some PKH26 fluorescent labelled cells ([Fig. 4A](#f4-ijsc-11-205){ref-type="fig"}) and in group IV few GFP fluorescent labelled cells were evident among the acini and islets ([Fig. 4B](#f4-ijsc-11-205){ref-type="fig"}).

In CD44 immunostained sections, group I showed −ve IE ([Fig. 5A](#f5-ijsc-11-205){ref-type="fig"}). Group II demonstrated multiple +ve spindle cells among the islets and pancreatic acini in few fields ([Fig. 5B](#f5-ijsc-11-205){ref-type="fig"}). While group III recruited multiple + ve cells and group IV some +ve cells among the islets and acini in multiple fields ([Fig. 5C, D](#f5-ijsc-11-205){ref-type="fig"}).

In insulin immunostained sections, group I showed +ve IE among most of the islet cells, in group II shrunken islets recruited +ve IE among few cells, in group III +ve IE was seen among multiple islet cells and group IV clarified +ve IE among most of the islet cells ([Fig. 6A, B, C, D](#f6-ijsc-11-205){ref-type="fig"}).

### Morphometric results ([Table 2](#t2-ijsc-11-205){ref-type="table"})

Concerning the mean area % of collagen fibers, a significant increase was found in group II compared to the other groups. The mean area % of CD44 +ve cells revealed a significant increase in group III compared to groups II and IV, in addition in group IV compared to group II.

The mean area % of insulin +ve IE denoted a significant decrease in group II compared to the other groups and in group III compared to groups I and IV.

### PCR results

The mean values of PCR±SD were (1.93±0.30) in group I, (0.14±0.04) in group II, (0.61±0.08) in group III and (1.59±0.11) in group IV. The previous values indicated a significant decrease in the group II compared to the other groups and in group III compared to groups I & IV.

Discussion
==========

The present study aimed at investigating the therapeutic effect of SERCA2b gene transfected AMSCs on the pancreas of streptozotocin (STZ)-induced diabetes type 1 in adult male albino rat and comparing it to that of non-transfected AMSCs.

In the present study single dose of STZ has been administered to rodents, which were sacrified 3 weeks following the day of confirmation of diabetes. The aim was to establish a model of T1DM and provide the optimal time to assess serological and morphological events underlying T1DM in rat. This was confirmed by de Senna et al. ([@b28-ijsc-11-205]).

Diabetic group (Group II) showed shrunken islets exhibiting few cells with absent secretory granules, denoting degenerative changes. Increased collagen content indicated fibrotic changes and was confirmed by a significant increase in the mean area % of collagen fibers. In accordance, it was mentioned that decrease in number and size of the pancreatic islets and beta cells degranulation were commonly reported in T1DM. Oxidative stress and increased accumulation of ROS induce beta cell damage ([@b29-ijsc-11-205]).

In group II, few CD44+ ve spindle cells were seen and a significant decrease in the mean area % of insulin +ve IE was recorded. The previous results indicated autoimmune destruction of the insulin producing *β--*cells as documented by Martinov et al. ([@b30-ijsc-11-205]). It was proved that MSCs exhibit a surface marker profile +ve for CD44 ([@b31-ijsc-11-205]). It was added that diabetes negatively impacts on functional properties of tissue resident SCs with consequent defective regeneration ([@b32-ijsc-11-205]).

As regards PCR values, a significant decrease in *SERCA2b* gene was recorded in group II. In agreement, it was reported that islets isolated from diabetic db/db mice lacked *SERCA2b*, the main *SERCA* isoform expressed in pancreatic *β*-cells, and revealed altered Ca^2+^ oscillations ([@b6-ijsc-11-205]). In addition, a significant decrease was recorded in the mean isolated islet calcium values in the diabetic group. In support, it was mentioned that in STZ-treated isolated islet, the intracellular calcium level was decreased. This was referred to changes in the expression of cellular calcium-channels (Cav1.2 and PMCA). In addition, down-regulation of ER calcium-transporters such as *SERCA2b* implies depletion of the ER calcium pool resulting in ER stress ([@b33-ijsc-11-205]).

A significant increase was reported in the mean blood glucose values in group II compared to the control and treated groups, in accordance to Li et al. ([@b34-ijsc-11-205]). On the other hand, a significant decrease was detected in the mean plasma insulin values, the previous finding was confirmed in STZ-DM rats ([@b19-ijsc-11-205]).

In AMSCs group, few islet cells with condensed nuclear chromatin were evident. The previous results indicated regression of induced diabetic degenerative changes by AMSCs therapy. This outcome was concomitant with Gerace et al. ([@b35-ijsc-11-205]), who documented that MSC interventions demonstrated improved T1DM outcomes through MSC migration to areas of pancreatic injury. In addition, MSCs modify the islet microenvironment to promote the survival and regeneration of surviving *β* cells and abrogate inherent autoimmunity against *β* cells.

Group III showed minimal increase in the collagen content between the lobules, among the islet cells and around vessels. In support, it was suggested that the antifibrotic effect of MSCs is mediated through immune modulation, inhibition of TGF*β*-mediated differentiation of various cells types into myofibroblasts and inhibition of oxidative stress ([@b36-ijsc-11-205]).

In group III characterization of the cultured cells by immunohistochemistry and immunophenotyping proved that they were CD44 +ve. Some PKH26 fluorescent labelled cells, in addition to multiple CD44+ ve cells were detected among the islet cells and acini in multiple fields. A significant increase in the mean area % of CD44 +ve cells compared to groups II and IV was confirmative. The previous results denoted homing of the injected AMSCs, the ability of transplanted MSCs to engraft and regenerate injured tissues, in addition to increasing mobilization of the endogenous stem cells as confirmed by Aboul-Fotouh et al. ([@b10-ijsc-11-205]).

Positive insulin IE was evident among multiple islet cells in the AMSCs group, confirmed by a significant increase in the mean area % of IE compared to group II. In agreement, Liu et al. ([@b37-ijsc-11-205]) mentioned that in case of treatment with MSCs, *β*-cells insulin immunoreactions were obviously improved and referred the previous findings to the multipotency of MSCs and their abililty to transdifferentiate into insulin producing *β* cells.

SERCA2b transfected AMSCs group recruited accidental condensed nuclear chromatin and fine collagen fibers. The previous results denoted minimal residual degenerative and fibrotic changes compared to groups II and III. This denoted a rapid and effective regenerative process. In accordance, a novel therapeutic approach using *SERCA2b* gene was suggested to stabilize the intracellular Ca^2+^ level in the pancreas of diabetic patients ([@b38-ijsc-11-205]).

In group IV, characterization of the cultured gene transfected AMSCs by GFP labeling and immunophenotyping proved transfection of more than 90% of cells. Few GFP labeled cells and fewer CD44 +ve cells were evident among the acini and islets, compared to group III. In addition, +ve insulin IE was found among most of the islet cells, confirmed by a significant increase in the mean area % of the IE compared to groups II and III.

The previous changes can be explained by more pronounced trans-differentiation of *SERCA2b* modified AMSCs into insulin producing *β* cells with morphological trans-differentiation and higher efficiency of the *SERCA2b* modified AMSCs regenerative plasticity. In support, it was documented that normal regeneration, repair and consequently function of pancreatic *β* cells can be referred to normal *SERCA2b* level. It was added that intracellular Ca^2+^ homeostasis is cruicial for cell proliferation, migration and differentiation ([@b39-ijsc-11-205]).

As regards PCR values, a significant decrease in *SERCA2b* gene was recorded in AMSCs group compared to control and *SERCA2b* treated group. The previous finding can be referred to the injection of genetically modified AMSCs transfected by *SERCA2b* gene. Concomitantly, it was confirmed and proved that level of *SERCA2a* gene upgraded by gene therapy ([@b40-ijsc-11-205]). In addition, a significant increase in isolated islet calcium level was recorded in *SERCA2b* treated group compared to group III providing more evidence to support that *SERCA2b* improves the therapeutic efficacy of AMSCs.

The lowered blood glucose level in AMSCs and *SERCA2b* transfected AMSCs treated groups can be related to regeneration of the islet *β* cells and improved endogenous insulin secretion. In addition, a significant increase in plasma insulin and islet calcium levels was recorded in *SERCA2b* treated group compared to group III providing more evidence to support that *SERCA2b* improve the therapeutic efficacy of AMSCs, yet the recovery is better confirmed by all the assessment parameters.

It can be concluded that diabetes type 1 induced pancreatic degenerative changes. AMSCs and *SERCA2b* gene modified AMSCs therapy proved definite therapeutic effect by regression of degenerative changes. The regenerative effect was more obvious in response to *SERCA2b* gene modified AMSCs, suggesting its potential use as a therapeutic modality for diabetes. The severity of degenerative changes and the comparative therapeutic effect were confirmed by histological, morphometric, biochemical and serological studies.

Professor Laila Ahmed Rashed, Department of Biochemistry, Faculty of Medicine, Cairo University, Egypt performed biochemical and serological procedures. Mr. Kareem Hassan technician at Medical Histology and Cell Biology Department contributed to specimens preparation.
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![Showing: (A) CD44 +ve spindle cells (arrows). (B) CD34 −ve immunoreactivity (arrows) (Phase contrast microscopy×100). (C) Immunophenotyping of AMSCs 96% are +ve for CD44 (Flow Cytometry). (D) Transfected cells appearing mostly as spindle fluroscent labeled cells (GFP×100). (E) Immunophenotyping of transfected AMSCs showed 93.3% of the cells GFP labeled (Flow Cytometry).](ijsc-11-205f1){#f1-ijsc-11-205}

![Showing: (A) the islet cells exhibiting pale nuclei (N) and secretory granules (g) in group I. (B) a shrunken islet (s) exhibiting fibroblasts (f) and few cells with absent secretory granules in group II. (C) condensed nuclear chromatin (cc) of an islet cell, multiple pale nuclei (N) and secretory granules (g) in group III. (D) condensed nuclear chromatin (cc) of an islet cell, pale nuclei (N) and secretory granules (g) in most islet cells of group IV (Toluidine blue, ×1000).](ijsc-11-205f2){#f2-ijsc-11-205}

![Showing: (A) fine collagen fibers between the acini (arrows) and among the islet cells (arrowheads) in group I. (B) multiple collagen fibers between the acini (arrows) and among the islet cells (arrowheads) in group II. (C) minimal increase in the collagen content (arrow) around a vessel (V) and fine collagen fibers among the islet cells (arrowheads) in group III. (D) fine collagen fibers between the acini (arrow) and among the islet cells (arrowhead) in group IV (Masson's Trichrome, ×200).](ijsc-11-205f3){#f3-ijsc-11-205}

![Showing: (A) some fluorescent labeled cells (arrows) among pancreatic acini and an islet (rectangle) in group III (PKH26, ×100). (B) Few fluorescent labeled cells (arrows) among pancreatic acini and an islet (rectangle) in group IV (GFP, ×100).](ijsc-11-205f4){#f4-ijsc-11-205}

![Showing: (A) −ve IE in group I. (B) multiple +ve spindle cells among islet cells (arrows) and acini (thick arrow) in group II. (C) multiple +ve cells among islet cells (arrows) and acini (thick arrow) in group III. (D) some +ve cells among islet cells (arrow) and acini (thick arrow) in group IV (CD44 immunostaining, ×400).](ijsc-11-205f5){#f5-ijsc-11-205}

![Showing: +ve IE among (arrowhead): (A) most of islet cells in group I. (B) few cells in a shrunken islet of group II. (C) multiple islet cells in group III. (D) most islet cells in group IV (Insulin immunostaining, ×400).](ijsc-11-205f6){#f6-ijsc-11-205}

###### 

Mean values±SD of blood glucose and plasma insulin levels in control and experimental groups

  Groups      Blood glucose level                                            Plasma insulin level
  ----------- -------------------------------------------------------------- ------------------------------------------------------
  Group I     97.5±7.2 mg/dl                                                 0.89±0.02
  Group II    442.8±19.78 mg/dl[a](#tfn1-ijsc-11-205){ref-type="table-fn"}   0.54±0.03[b](#tfn2-ijsc-11-205){ref-type="table-fn"}
  Group III   158.2±6.71 mg/dl                                               0.67±0.03[c](#tfn3-ijsc-11-205){ref-type="table-fn"}
  Group IV    129.3±6.12 mg/dl                                               0.84±0.04

Significant increase compared to the other groups.

Significant decrease compared to the other groups.

Significant decrease compared to groups I and IV.

###### 

Mean±SD of the area % of collagen fibers, area % of CD44 +ve cells and area % of insulin +ve IE in control and experimental groups

  Groups      Area % of collagen fibers                              Area % of CD44+ve cells                                Area % of insulin +ve IE
  ----------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  Group I     0.24±0.05                                              \-                                                     1.24±0.15
  Group II    2.43±0.62[a](#tfn4-ijsc-11-205){ref-type="table-fn"}   0.39±0.11                                              0.25±0.08[d](#tfn7-ijsc-11-205){ref-type="table-fn"}
  Group III   0.28±0.05                                              1.29±0.31[b](#tfn5-ijsc-11-205){ref-type="table-fn"}   0.63±0.16[e](#tfn8-ijsc-11-205){ref-type="table-fn"}
  Group IV    0.26±0.04                                              0.89±0.20[c](#tfn6-ijsc-11-205){ref-type="table-fn"}   1.06±0.10

Significant increase compared to the other groups.

Significant increase compared to groups II and IV.

Significant increase compared to group II.

Significant decrease compared to the other groups.

Significant decrease compared to groups I and IV.
